EMA Paediatric Investigation Plans Training Course

DIA's Paediatric Investigation Plans course is run in person inside the European Medicines Agency's own Amsterdam building — DIA calls it the only in-person EMA training course giving a full introduction to PIPs — 5–6 November 2026, with EMA's own Paediatric Medicines Office on the teaching faculty.

Dates and format

• Dates: 5–6 November 2026 (Thursday–Friday)
• Format: in-person training course, held at the EMA's own Amsterdam building
• Day one: 8:00 a.m.–5:00 p.m.
• Organizer: DIA (Drug Information Association), co-taught by EMA's Paediatric Medicines Office

What it covers

DIA markets this as the only in-person EMA course giving a full introduction to Paediatric Investigation Plans. Published topics span the EU Paediatric Regulation and the Global Paediatric Plan, special-case issues, how a PIP opinion is reached, and how a plan is managed across its lifecycle — delivered through interactive lectures, real-world case discussion and practical workshop sessions, with EMA's own Paediatric Medicines Office represented on the faculty alongside DIA's course team.

Who should attend

DIA aims the course at regulatory affairs, clinical research and project-management professionals who will be involved in paediatric medicines development — whether drafting a first PIP or managing one through amendment and compliance checks. A limited-seat discount for organisations on EMA's SME register makes it worth checking eligibility before registering at the standard rate.

Comparing EMA's own open programming the same week? EMA's SME Info Day runs 6 November, also hybrid in Amsterdam, and DIA's Advanced Pharmacovigilance Audits and Inspections course runs virtually the same week. The full events directory lists everything we have verified.